Suchergebnisse - "Derhovanessian, Evelyna"
-
1
Cytomegalovirus and human immunosenescence
ISSN: 1052-9276, 1099-1654, 1099-1654Veröffentlicht: Chichester, UK John Wiley & Sons, Ltd 01.01.2009Veröffentlicht in Reviews in medical virology (01.01.2009)“… ‘Immunosenescence’ is an imprecise term used to describe deleterious age‐associated changes to immune parameters observed in all mammals studied so far …”
Volltext
Journal Article -
2
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients
ISSN: 1537-4513, 1537-4513Veröffentlicht: United States 01.06.2009Veröffentlicht in Journal of immunotherapy (1997) (01.06.2009)“… In mice, injection of messenger RNA (mRNA) coding for tumor-associated antigens can induce antitumor immune responses and therefore offers a broadly applicable …”
Weitere Angaben
Journal Article -
3
Immunity, ageing and cancer
ISSN: 1742-4933, 1742-4933Veröffentlicht: London BioMed Central 24.09.2008Veröffentlicht in Immunity & ageing (24.09.2008)“… Compromised immunity contributes to the decreased ability of the elderly to control infectious disease and to their generally poor response to vaccination. It …”
Volltext
Journal Article -
4
Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people
ISSN: 1742-4933, 1742-4933Veröffentlicht: London BioMed Central 25.07.2008Veröffentlicht in Immunity & ageing (25.07.2008)“… Background T cell-mediated immunity in elderly people is compromised in ways reflected in the composition of the peripheral T cell pool. The advent of …”
Volltext
Journal Article -
5
Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis
ISSN: 1527-7755, 1527-7755Veröffentlicht: United States 20.05.2012Veröffentlicht in Journal of clinical oncology (20.05.2012)“… To analyze the prognostic relevance of circulating T cells responding to NY-ESO-1, Melan-A, MAGE-3, and survivin in patients with melanoma with distant …”
Weitere Angaben
Journal Article -
6
Hallmark features of immunosenescence are absent in familial longevity
ISSN: 1550-6606, 1550-6606Veröffentlicht: United States 15.10.2010Veröffentlicht in The Journal of immunology (1950) (15.10.2010)“… Seropositivity for CMV is one of the parameters of the "immune risk profile" associated with mortality in longitudinal studies of the very elderly and may …”
Weitere Angaben
Journal Article -
7
Effect of Culture at Low Oxygen Tension on the Expression of Heat Shock Proteins in a Panel of Melanoma Cell Lines
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 22.06.2012Veröffentlicht in PloS one (22.06.2012)“… Tumours are commonly hypoxic and this can be associated with aggressive tumour type, metastasis and resistance to therapy. Heat shock proteins (hsps) are …”
Volltext
Journal Article -
8
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
ISSN: 2666-6065, 2666-6065Veröffentlicht: Elsevier Ltd 01.12.2022Veröffentlicht in The Lancet regional health. Western Pacific (01.12.2022)“… BNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals are limited. This phase 2, …”
Volltext
Journal Article -
9
391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors
ISSN: 2051-1426Veröffentlicht: London BMJ Publishing Group LTD 01.11.2020Veröffentlicht in Journal for immunotherapy of cancer (01.11.2020)“… BackgroundmRNA-based-drugs can be applied for cancer immunotherapy.1 SAR441000 is a novel saline-formulated mixture of four mRNAs encoding interleukin-12 …”
Volltext
Journal Article -
10
Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study
ISSN: 1742-4933, 1742-4933Veröffentlicht: London BioMed Central 28.08.2012Veröffentlicht in Immunity & ageing (28.08.2012)“… Background Cytomegalovirus (CMV) infection has been reported to contribute to the pathogenesis of type 1 diabetes and post-transplantation diabetes. However, …”
Volltext
Journal Article -
11
Inflammation, ageing and chronic disease
ISSN: 0952-7915, 1879-0372, 1879-0372Veröffentlicht: England Elsevier Ltd 01.08.2014Veröffentlicht in Current opinion in immunology (01.08.2014)“… •Elderly people commonly show signs of low level systemic inflammation.•Causes include presence of senescent cells, chronic infections and obesity.•Systemic …”
Volltext
Journal Article -
12
Immunosenescence and Cytomegalovirus: where do we stand after a decade?
ISSN: 1742-4933, 1742-4933Veröffentlicht: London BioMed Central 07.09.2010Veröffentlicht in Immunity & ageing (07.09.2010)“… [...] an important question becomes whether the CMV-sensitive altered immune cell subset distributions in the elderly, particularly the decreased numbers and …”
Volltext
Journal Article -
13
Role of CMV in immune senescence
ISSN: 0168-1702, 1872-7492, 1872-7492Veröffentlicht: Netherlands Elsevier B.V 01.05.2011Veröffentlicht in Virus research (01.05.2011)“… “Immune senescence” is a descriptive term for the deleterious age-associated changes to immunity observed in all mammals studied so far. While all components …”
Volltext
Journal Article -
14
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 01.06.2023Veröffentlicht in Nature (London) (01.06.2023)“… Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients 1 , yet harbours mutation-derived T cell neoantigens that are suitable for vaccines 2 , 3 …”
Volltext
Journal Article -
15
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 03.09.2020Veröffentlicht in Nature (London) (03.09.2020)“… Treating patients who have cancer with vaccines that stimulate a targeted immune response is conceptually appealing, but cancer vaccine trials have not been …”
Volltext
Journal Article -
16
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 22.10.2020Veröffentlicht in Nature (London) (22.10.2020)“… An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, …”
Volltext
Journal Article -
17
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 16.06.2016Veröffentlicht in Nature (London) (16.06.2016)“… The development of a nanoparticle RNA vaccine is reported that preferentially targets dendritic cells after systemic administration, and is shown to provide …”
Volltext
Journal Article -
18
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 22.07.2021Veröffentlicht in Nature (London) (22.07.2021)“… BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion …”
Volltext
Journal Article -
19
Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients
ISSN: 1465-542X, 1465-5411, 1465-542XVeröffentlicht: London BioMed Central 10.03.2015Veröffentlicht in Breast cancer research : BCR (10.03.2015)“… Introduction Breast cancer is one of the most common cancers among women. Its incidence is increasing in many countries and a higher number of older women are …”
Volltext
Journal Article -
20
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
ISSN: 0028-0836, 1476-4687, 1476-4687Veröffentlicht: London Nature Publishing Group UK 13.07.2017Veröffentlicht in Nature (London) (13.07.2017)“… The authors report the first-in-human application of personalized neo-antigen RNA vaccines in patients with melanoma. Personalized cancer vaccine trials …”
Volltext
Journal Article